Tower Research Capital (TRC)’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
Tower Research Capital (TRC)'s VIR Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its Vir Biotechnology (VIR) stake by 558% in Q3 2026, buying an estimated $291K and bringing the position to 34,363 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #1894.
Tower Research Capital (TRC) first reported a position in VIR in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.55M in Q3 2020. 266 funds tracked by Wall St. Rank hold VIR as of Q3 2026.
- Tower Research Capital (TRC) held 34,363 shares of Vir Biotechnology worth $384K as of Q3 2026.
- Tower Research Capital (TRC) bought 29,141 Vir Biotechnology shares in Q3 2026, an estimated $291K.
- Vir Biotechnology made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #1894 holding.
- Tower Research Capital (TRC) first reported a position in Vir Biotechnology in Q4 2019 and has held it in 27 quarters since.
- Tower Research Capital (TRC)'s Vir Biotechnology position peaked at $1.55M in Q3 2020.
- 266 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.